Susquehanna International Group, LLP Zentalis Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.9 - $4.57 $95,700 - $150,810
33,000 New
33,000 $121,000
Q4 2023

Feb 14, 2024
BUY
$9.84 - $20.13 $125,952 - $257,664
12,800 Added 73.56%
30,200 $457,000
Q3 2023

Nov 14, 2023
SELL
$19.63 - $28.29 $363,155 - $523,365
-18,500 Reduced 51.53%
17,400 $349,000
Q2 2023

Aug 11, 2023
BUY
$17.41 - $30.05 $625,019 - $1.08 Million
35,900 New
35,900 $1.01 Million

Others Institutions Holding ZNTL

# of Institutions
142
Shares Held
68M
Call Options Held
48.5K
Put Options Held
89.6K
View Full List

About Zentalis Pharmaceuticals, Inc.

ZNTL Quotes by TradingView
  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $198M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email